Cover Image

Emerging phosphodiesterase inhibitors for treatment of neurodegenerative diseases

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Yu Xiang, Swapna Naik, Liyun Zhao, Jianyou Shi, Hengming Ke
Format:	Artículo Open Access
Published:	Wiley 2024
Subjects:	Medicinal Research Reviews
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Polymer nanotherapeutics: A promising approach toward microglial inhibition in neurodegenerative diseases
by: Sanaz Keshavarz Shahbaz, et al.
Published: (2024)

Indirect influence on the BDNF/TrkB receptor signaling pathway via GPCRs, an emerging strategy in the treatment of neurodegenerative disorders
by: Mirjana Antonijevic, et al.
Published: (2024)

The recent advance and prospect of poly(ADP‐ribose) polymerase inhibitors for the treatment of cancer
by: Yi‐Ru Bai, et al.
Published: (2024)

Advances in reversible covalent kinase inhibitors
by: Zheng Zhao, et al.
Published: (2024)

Natural products as IL‐6 inhibitors for inflammatory diseases: Synthetic and SAR perspective
by: Dipesh S. Harmalkar, et al.
Published: (2024)

Poly (adenosine diphosphate‐ribose) polymerase inhibitors in the treatment of triple‐negative breast cancer with homologous repair deficiency
by: Peng Yuan, et al.
Published: (2024)

OGG1: An emerging multifunctional therapeutic target for the treatment of diseases caused by oxidative DNA damage
by: Yunxiao Zhong, et al.
Published: (2024)

Innovative pathological network‐based multitarget approaches for Alzheimer's disease treatment
by: Paloma Mayo, et al.
Published: (2024)

Recent advances in dietary androgen receptor inhibitors
by: Li Ren, et al.
Published: (2024)

A Focus on Natural Autophagy Modulators as Potential Host‐Directed Weapons Against Emerging and Re‐Emerging Viruses
by: Ilaria Cursaro, et al.
Published: (2025)

The Evolution of Benzodiazepine Allosteric Modulators: Structural Insights From Historical Milestones to Emerging Innovations in Drug Discovery and Development
by: Hongyu Jiang, et al.
Published: (2025)

Human Cyclophilins—An Emerging Class of Drug Targets
by: Katarina Jurkova, et al.
Published: (2025)

Targeting ClpP Protease: Emerging Therapeutic Strategies and Small‐Molecule Modulators in Drug Discovery
by: Lihua Liu, et al.
Published: (2026)

Emerging roles of nerve‐bone axis in modulating skeletal system
by: Jingya Li, et al.
Published: (2024)

The Emerging Landscape of Tubercular Targets: A Medicinal Chemistry Approach
by: Baji Baba Shaik, et al.
Published: (2025)

Beyond dopamine: Novel strategies for schizophrenia treatment
by: Paulina Dudzik, et al.
Published: (2024)

Preclinical evidence using synthetic compounds and natural products indicates that AMPK represents a potential pharmacological target for the therapy of pulmonary diseases
by: Chao Yang, et al.
Published: (2024)

The role of Toll‐like receptors in neuropsychiatric disorders: Immunopathology, treatment, and management
by: Kiarash Saleki, et al.
Published: (2024)

Multi‐Targeting Ligands as Prospective Therapeutics for Alzheimer's Disease, a Prevalent Neurodegenerative Disorder: Mechanistic Insights, Emerging Targets and Drug Discovery Campaigns
by: Amandeep Thakur, et al.
Published: (2026)

Therapeutic Potential of Vascular Adhesion Protein‐1 (VAP‐1)/Semicarbazide‐Sensitive Amine Oxidase (SSAO) Inhibitors: Current Medicinal Chemistry and Emerging Opportunities
by: Pinaki Bhattacharjee, et al.
Published: (2025)

Inside Front Cover Image, Volume 44, Issue 2
by: Yu Zheng, et al.
Published: (2024)

Targeting lysosomal quality control as a therapeutic strategy against aging and diseases
by: Yuchen He, et al.
Published: (2024)

Antineoplastics for treating Alzheimer's disease and dementia: Evidence from preclinical and observational studies
by: Viswanath Das, et al.
Published: (2024)

An overview of the progress made in research into the Mpox virus
by: Yansheng Li, et al.
Published: (2024)

Recent Developments in the Optical Control of Adrenergic Signaling
by: Shuang Shi, et al.
Published: (2025)

Near‐Infrared Fluorescent Probe for the Early Diagnosis of Alzheimer's Disease
by: Yan Liu, et al.
Published: (2025)

Danshensu Derivatives: A Series of Promising Drugs With Protective Effects Against Cardiocerebrovascular Diseases and Cancers
by: Yang Yang, et al.
Published: (2025)

Enhancing healthy aging with small molecules: A mitochondrial perspective
by: Xiujiao Qin, et al.
Published: (2024)

Mucin O‐Glycosylation and Mucolytic Therapies in Pseudomyxoma Peritonei: Literature Review
by: Qi‐Di Zhao, et al.
Published: (2026)

A Possibility of Synthetic Lethality: Wee1 Kinase as a Promising Treating Target for Cancer
by: Xin Xue, et al.
Published: (2026)

Front Cover Image, Volume 44, Issue 5
by: Qian Zhao, et al.
Published: (2024)

Harnessing the Power of Natural Products for Targeted Protein Degradation
by: Bo Zhu, et al.
Published: (2025)

Inside Front Cover Image, Volume 44, Issue 5
by: Shuai‐Jiang Liu, et al.
Published: (2024)

Bioactive atropisomers: Unraveling design strategies and synthetic routes for drug discovery
by: Shuai‐Jiang Liu, et al.
Published: (2024)

Synthesis and Clinical Application of Small‐Molecule Drugs Approved by FDA in 2025
by: Liang Chang, et al.
Published: (2026)

Canonical effects of cytokines on glomerulonephritis: A new outlook in nephrology
by: Sepideh Zununi Vahed, et al.
Published: (2024)

A comprehensive review on the development of chiral Cu, Ni, and Zn complexes as pharmaceutical agents over the past decades: Synthesis, molecular structure and biological activity
by: Zahra Kazemi, et al.
Published: (2024)

H+‐slip correlated to rotor free‐wheeling as cause of F1FO‐ATPase dysfunction in primary mitochondrial disorders
by: Salvatore Nesci, et al.
Published: (2024)

Issue Information
Published: (2024)

Metal complexes bearing EGFR‐inhibiting ligands as promising anticancer agents
by: Xiaoyan Ma, et al.
Published: (2024)